At TCS, we don’t just help businesses transform. We help them become perpetually adaptive enterprises, built to evolve continuously and confidently in a world of constant change.
We deliver excellence and create value for customers and communities - everyday. With the best talent and the latest technology we help customers turn complexity into opportunities and create meaningful change.
Point of views, research, studies - on the latest themes - to help you expand your knowledge and be future ready.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
TCS ADD ™ Platforms / Article
Hilde Vanaken
Senior Industry Advisor, TCS Life Sciences and Healthcare
Priyanka Sawant
Head, TCS ADD Patient and Site Engagement
You have these already downloaded
We have sent you a copy of the report to your email again.
The COVID-19 pandemic has stalled multiple businesses and processes across the globe including clinical trials since there are critical activities that are carried out on site in-person such as informed consent. The impact is not just seen for new patients but also for existing patients who are required to provide re-consents in accordance with the COVID-19-led changes. To overcome these challenges, an expedited introduction and onboarding of an electronic consenting tool could be a solution. The virtual approach will enable sites to connect with patients without the need for in-person visits. This paper explores digital/virtual approaches to informed consent that could reinstate clinical trials and proceeds to study real-life implementation that Roche has executed to solve its remote consenting challenges for COVID-19 impacted clinical trials.
AI in Pharmacovigilance – Accelerating Innovation
AR/VR Revolutionizing Clinical Trial Monitoring and Data Analysis
AI-empowered Metadata Governance Wins Best Paper at PharmaSUG 2025
AI + Pharmacovigilance – When One Plus One is More Than Two